Loading...
Eat, Sleep, Console for Neonatal Abstinence Syndrome Babies
Patton, Kathryn
Patton, Kathryn
Citations
Altmetric:
License
DOI
Abstract
Neonatal Abstinence Syndrome (NAS) is a complex disorder that manifests with neurologic, gastrointestinal, and musculoskeletal disturbances and is most often associated with opioid withdrawal. In the US, 6 out of 1,000 babies are born to mothers who used opioids during their pregnancy. These babies go on to develop NAS. Androscoggin County, where Central Maine Medical Center is located, has an even higher rate of babies with NAS: 100 out of 1,000. Most institutions use the Finnegan Neonatal Abstinence Scoring System (FNASS) to guide pharmacologic treatment. This system assigns a score based on 21 clinical signs of withdrawal with a score ≥8 indicating a need for pharmacologic treatment. This system has never been validated nor has its score cutoffs been tested which may lead to over or under treatment of babies experiencing NAS. Eat, Sleep, Console is a novel approach which has shown to decrease average length of stay, pharmacologic treatment, and healthcare costs.
Description
Date
2019-01-01
Journal Title
Journal ISSN
Volume Title
Publisher
Collections
Files
ESC_for_NAS.pdf
Adobe PDF, 510.01 KB
- Available to administrators